Back to Journals » Infection and Drug Resistance » Volume 15
Effectiveness of Disc Diffusion Method for Vancomycin Sensitivity Testing of Staphylococcus aureus [Letter]
Received 22 February 2022
Accepted for publication 3 March 2022
Published 14 March 2022 Volume 2022:15 Pages 1027—1028
DOI https://doi.org/10.2147/IDR.S363499
Checked for plagiarism Yes
Editor who approved publication: Professor Suresh Antony
Nitin Kumar, Sourav Sen
Department of Microbiology, Symbiosis Medical College for Women, Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra, India
Correspondence: Nitin Kumar, Department of Microbiology, Symbiosis Medical College for Women, Symbiosis International (Deemed University) (SIU), Lavale, Pune, Maharashtra, India, Email [email protected]
View the original paper by Dr Ennab and colleagues
Dear editor
We read this study1 with great interest. This study focused on isolation, identification and antibiotic sensitivity pattern of bacterial isolates from postsurgical site infections in public hospitals in Northern Jordan. The study mentioned various methods to identify bacterial isolates, which were further subjected to antibiotic sensitivity testing as per CLSI guidelines.2
We would like to add some comments regarding this study and suggest the criteria for identification and antibiotic sensitivity testing need to be urgently revisited:
- A minor change needs to be made in the title, which indicates it as a multicentric study involving several hospitals in Northern Jordan, whereas author has collected samples from one single hospital.
- The susceptibility testing using vancomycin against Staphylococcus aureus is not recommended by any disk diffusion method as per CLSI guidelines.2 Authors in the present study have used vancomycin 30 µg disc against Staphylococcus aureus.
- Authors have reported that 87.5% of Staphylococcus aureus were sensitive to vancomycin, which is not acceptable due to the use of incorrect methodology. In this context, Vancomycin Resistant Staphylococcus aureus (VRSA) being a high priority pathogen as per WHO report-2017 should be identified by the currently acceptable method(s).3
Nevertheless, we congratulate the authors who focused on characterizing pathogenic isolates from various postsurgical site infection in a public health hospital in Northern Jordan.
Disclosure
The authors report no conflicts of interest in this communication.
References
1. Ennab R, Al-Momani W, Al-Titi R, Elayan A. Antibiotic profile of pathogenic bacteria isolated from postsurgical site infections in public hospitals in Northern Jordan. Infect Drug Resist. 2022;15:359–366. doi:10.2147/IDR.S350406
2. Xu Y, Wang B, Zhao H, et al. In vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from Chinese hospitals in 2018–2020. Infect Drug Resist. 2021;14:5449–5456. doi:10.2147/IDR.S340623
3. WHO. Media Centre. News Release. WHO publishes list of bacteria for which new antibiotics are urgently needed; 2017. Available from: http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/.
© 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.